Novo Nordisk Pharmatech A/S: Financial statements 2015
CVR: 13246149
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Novo Nordisk Pharmatech A/S (CVR 13246149) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 505,233,000 and a net result of DKK 92,104,000 compared with DKK 55,343,000 the year before. That is an increase of 2% compared with the year before. The profit margin was 18.2%. Equity in the 2015 report amounted to DKK 400,921,000. The solvency ratio was 64.8%. The company had 150 employees in the financial year.
- Revenue
- DKK 505,233,000
- Gross Profit
- DKK 228,049,000
- Profit/Loss
- DKK 92,104,000
- Equity
- DKK 400,921,000
- Total Assets
- DKK 618,589,000
- Employees
- 150
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 505.2M | 228M | 92.1M | 400.9M | 150 |
| 2014 | 495.2M | 176.6M | 55.3M | 336.8M | 150 |
| 2013 | 498M | 170.7M | 46.7M | 304.5M | 141 |
Official annual report
How creditworthy is Novo Nordisk Pharmatech A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 24, 2015, Lene Due Svensson has left the board of directors of Novo Nordisk Pharmatech A/S.
On August 28, 2015, the company changed its name from FEF CHEMICALS A/S to Novo Nordisk Pharmatech A/S.
Novo Nordisk Pharmatech A/S has published its annual report for 2014. Revenue came to DKK 495,202,000, and the net result was DKK 55,343,000.
As of January 23, 2015, Michael Fugl Hallgren has joined the board of directors of Novo Nordisk Pharmatech A/S.
As of January 23, 2015, Henrik Ehlers Wulff has joined the board of directors of Novo Nordisk Pharmatech A/S.
As of January 23, 2015, Per Toft Valstorp has left the board of directors of Novo Nordisk Pharmatech A/S.
As of January 23, 2015, Jan Hoff has left the board of directors of Novo Nordisk Pharmatech A/S.
About Novo Nordisk Pharmatech A/S
Novo Nordisk Pharmatech A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1989. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named FEF CHEMICALS A/S and FERROSAN FINE CHEMICALS A/S. The management consists of Ulla Grove Krogsgaard Thomsen. The board consists of Mette Sofie Mørck Jarl (chair), Christian Brøgger Stolberg, Jacob Sten Petersen and Joachim Juel Hagemeister. The company is owned by NOVO NORDISK A/S. The company has 489 employees (2026). In 2025, the company reported revenue of DKK 1,041,584,000 and a net result of DKK 113,891,000 compared with DKK 60,619,000 the year before. Equity in the 2025 report amounted to DKK 2,441,318,000.
